ArticleJournal of the American Geriatrics Society2018
Individualizing Prevention for Older Adults.
Article in Journal of the American Geriatrics Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Frailty, Implantable Cardioverter Defibrillators, and Mortality: a Systematic Review.Journal of general internal medicine · 2019Pooled it
- Statins, Mortality, and Major Adverse Cardiovascular Events Among US Veterans With Chronic Kidney Disease.JAMA network open · 2023Trial
- Pravastatin for Primary Prevention in Older Adults: Restricted Mean Survival Time Analysis.Journal of the American Geriatrics Society · 2018Trial
- Why do older adults stop cancer screening? Findings from the Medicare Current Beneficiary Survey.Journal of the American Geriatrics Society · 2025Article
- Frailty and its association with long-term mortality among community-dwelling older adults aged 75 years and over.Israel journal of health policy research · 2024Article
- The role of statin therapy in older adults: best practices and unmet challenges.Expert review of cardiovascular therapy · 2024Review
- Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework.BMC geriatrics · 2023Review
- Review
- Age is just a number: the concept of time to benefit in older adults.European journal of hospital pharmacy : science and practice · 2023Article
- Do functional status and Medicare claims data improve the predictive accuracy of an electronic health record mortality index? Findings from a national Veterans Affairs cohort.BMC geriatrics · 2022Article
- Improving individualized prescription in patients with multimorbidity through medication review.BMC geriatrics · 2022Article
- Exploration of Symptom Scale as an Outcome for Deprescribing: A Medication Review Study in Nursing Homes.Pharmaceuticals (Basel, Switzerland) · 2022Article
- Individualized Medication Review in Older People with Multimorbidity: A Comparative Analysis between Patients Living at Home and in a Nursing Home.International journal of environmental research and public health · 2022Article
- Predictors of Adverse Outcomes in Healthy Aging Adults: Coronary Artery Disease, Lower Educational Status and Higher P-Selectin Levels.Clinical interventions in aging · 2022Article
- Factors Associated with the Detection of Inappropriate Prescriptions in Older People: A Prospective Cohort.International journal of environmental research and public health · 2021Observational
- Trajectories of Frailty in the 5 Years Prior to Death Among U.S. Veterans Born 1927-1934.The journals of gerontology. Series A, Biological sciences and medical sciences · 2021Article
- Therapeutic optimization through goal-oriented prescription in nursing homes.International journal of clinical pharmacy · 2021Review
- Characterizing the Heterogeneity of Aging: A Vision for a Staging System for Aging.Frontiers in public health · 2021Review
- Statin Discontinuation and Life-Limiting Illness in Non-Skilled Stay Nursing Homes at Admission.Journal of the American Geriatrics Society · 2020Article
- Cancer Screening Among Older Adults: a Geriatrician's Perspective on Breast, Cervical, Colon, Prostate, and Lung Cancer Screening.Current oncology reports · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Prevention can help older adults avoid illness by identifying and addressing conditions before they cause symptoms, but prevention can also harm older adults if conditions that are unlikely to cause symptoms in the individual's lifetime are identified and treated. To identify older adults who preventive interventions are most likely to benefit (and most likely to harm), we propose a framework that compares an individual's life expectancy (LE) with the time to benefit (TTB) for an intervention. If LE is less than the TTB, the individual is unlikely to benefit but is exposed to the risks of the intervention, and the intervention should generally NOT be recommended. If LE is longer than the TTB, the individual could benefit, and the intervention should generally be recommended. If LE is similar to the TTB, the individual's values and preferences should be the major determinant of the decision. To facilitate the use of this framework in routine clinical care, we explored ways to estimate LE, identified the TTB for common preventive interventions, and developed strategies for communicating with individuals. We have synthesized these strategies and demonstrate how they can be used to individualize prevention for a hypothetical beneficiary in the setting of a Medicare annual wellness visit. Finally, we place prevention in the context of curative and symptom-oriented care and outline how prevention should be focused on healthier older adults, whereas symptom-oriented care should predominate in sicker older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.